Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Atuka Inc. logo — A cure for Parkinson’s, faster, through the world’s best pre...

Atuka Inc.

A cure for Parkinson’s, faster, through the world’s best preclinical neuroscience.

Founded 2003 Canada Toronto, Canada 18 employees Pharmaceutical

General Information

Company Name Atuka Inc.
Founded Year 2003
Location Canada Toronto, Canada +2
Employees 18
Industries Pharmaceutical
Social

Get notified when Atuka Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Atuka Inc.

Atuka Inc. is a pharmaceutical startup dedicated to finding a cure for Parkinson’s disease through advanced preclinical neuroscience. With a team of highly experienced neuroscientists, the company has been collaborating with partners for over 20 years to expand the frontiers of Parkinson’s disease research and develop life-changing therapeutics. Founded by Dr. Jonathan Brotchie in 2003, Atuka has evaluated over 300 potential therapeutics and seen more than 30 of them progress to clinical trials, marking unparalleled experience in the field globally. The company has also worked with over 90 organizations, building a rich understanding of Parkinson’s disease and potential treatments through 400 preclinical projects. With diverse expertise and a commitment to ethical scientific research, Atuka operates from offices and facilities in Toronto and Suzhou. The company's slogan, "A cure for Parkinson’s, faster, through the world’s best preclinical neuroscience," exemplifies its relentless pursuit of finding innovative solutions for neurological disorders.

Taxonomy: Neurodegenerative disease research, Preclinical neuroscience, Therapeutic development, Parkinson's disease research, Biologics development, Clinical trials support, Collaborative research, DMPK and in-vivo imaging, Chemistry services, Biotech partnerships

No funding data available for Atuka Inc. yet.

Get notified when Atuka Inc. raises funding

Atuka Inc. Alternatives & Competitors

Atuka Inc. vs
PsychoGenics
PsychoGenics United States

Discover Your Next Breakthrough

Grant
146 employees
Biotechnology, Health Care
Atuka Inc. vs
Texas Biomedical Research Institute
Texas Biomedical Research Institute United States

Eradicating Infectious Disease

Grant
386 employees
Biotechnology, Education
Atuka Inc. vs
Nuvamid
Nuvamid Switzerland

A clinical stage biotech focused on the research and use of nucleotides, as therapeutics for rare di...

4 employees
Health Care, Manufacturing

FAQ About Atuka Inc.

A cure for Parkinson’s, faster, through the world’s best preclinical neuroscience.
Atuka Inc. was founded in 2003.
Atuka Inc. is headquartered in Toronto, Canada.
Atuka Inc. operates in the following industries: Pharmaceutical.
Atuka Inc. has approximately 18 employees.
Top alternatives and competitors to Atuka Inc. include PsychoGenics, Texas Biomedical Research Institute, Nuvamid, Addex Therapeutics, Oklahoma Medical Research Foundation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Atuka Inc. and PsychoGenics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Atuka Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy